atenolol has been researched along with Neurocutaneous Disorders in 2 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol has revolutionized the treatment of infantile hemangiomas, and other beta-blockers provide promising alternatives." | 2.52 | Beta-blockers for childhood vascular tumors. ( Bayart, CB; Brandling-Bennett, HA, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calderón-Castrat, X | 1 |
| Castro, R | 1 |
| Casamayor, E | 1 |
| Zavala, K | 1 |
| Bayart, CB | 1 |
| Brandling-Bennett, HA | 1 |
1 review available for atenolol and Neurocutaneous Disorders
| Article | Year |
|---|---|
Beta-blockers for childhood vascular tumors.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Atenolol; Child, Prescho | 2015 |
1 other study available for atenolol and Neurocutaneous Disorders
| Article | Year |
|---|---|
Phaces syndrome successfully treated with oral atenolol.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Aortic Coarctation; Atenolol; Eye Abno | 2020 |